Targeting herpes simplex virus with CRISPR–Cas9 cures herpetic stromal keratitis in miceDi Yin, Yujia Cai|Nature Biotechnology|2021Cited by 178
Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriersDi Yin, Yujia Cai, Zhijue Xu et al.|Nature Biomedical Engineering|2024Cited by 89
Modified lentiviral globin gene therapy for pediatric β0/β0 transfusion-dependent β-thalassemia: A single-center, single-arm pilot trialShiqi Li, Yujia Cai, Sikai Ling et al.|Cell stem cell|2024Cited by 77
Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapySikai Ling, Yujia Cai|Nature Nanotechnology|2025Cited by 63
A single dose SARS-CoV-2 simulating particle vaccine induces potent neutralizing activitiesDi Yin, Yujia Cai|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 10